Jeffrey Jones
Chief Tech/Sci/R&D Officer bei CULLINAN THERAPEUTICS, INC.
Vermögen: 2 Mio $ am 31.03.2024
Profil
Jeffrey Jones is currently the Chief Medical Officer at Cullinan Oncology, Inc. He previously worked as the Vice President-Global Drug Development & Lymphoma at Bristol Myers Squibb Co. from 2017 to 2022.
Prior to that, he was an Associate Professor at The Ohio State University College of Medicine and the Chief Medical Officer at Cullinan Oncology LLC.
Dr. Jones holds an MBA from Fisher College of Business, a doctorate from the University of Michigan Medical School, and a graduate degree from The University of Texas Health Science Center at Houston.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.02.2024 | 118 691 ( 0,28% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Jeffrey Jones
| Unternehmen | Position | Beginn |
|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 28.02.2022 |
Ehemalige bekannte Positionen von Jeffrey Jones
| Unternehmen | Position | Ende |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | 01.04.2020 |
| The Ohio State University College of Medicine | Corporate Officer/Principal | - |
Cullinan Oncology LLC
 Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Jeffrey Jones
| University of Michigan Medical School | Doctorate Degree |
| The University of Texas Health Science Center at Houston | Graduate Degree |
| Fisher College of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| CULLINAN THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Finance |
